Cholesterol Enzymatic Endpoint
510(k) K923504
Cholesterol Enzymatic Endpoint is a medical device (FDA Class I; FDA product code CHH, Enzymatic Esterase--Oxidase, Cholesterol) made by Randox Laboratories, Ltd., cleared under FDA 510(k) K923504 on 10 Jan 1994, active as of 22 Oct 2026. 2 FDA recalls are linked to it.
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK923504 | Date10 Jan 1994 | StatusActive |
Official records
- FDA 510(k) database K923504
From the FDA record
- Received by the FDA
- 15 Jul 1992
- FDA decision
- 10 Jan 1994 (Substantially Equivalent)
- FDA review time
- 544 days from receipt to decision
- Public document
- 510(k) statement on file with the FDA
Recalls
-
- Terminated Z-1424-2022
Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.
-
- Terminated Z-0328-2022
When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range
-
- Terminated Z-1652-2016
Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific
Timeline
- Cleared FDA 510(k) K923504
- Recall initiated FDA recalls Z-1652-2016
- Recall initiated FDA recalls Z-0328-2022
- Recall initiated FDA recalls Z-1424-2022
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- CHH
- Device class
- Class I
- Regulation
- 21 CFR Part 862.1175
- Advisory committee
- Clinical Chemistry
- FDA decision
- SESE Substantially Equivalent
Devices cleared under K923504
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| ADVIA® Chemistry CHOL_2 Cholesterol_2 Reagent 10376501 | 10376501 / 10376501 | 00630414561073 | No longer on the market | |
| ADVIA® Chemistry CHOL_c Cholesterol Reagents, Concentrated 10335874 | 4993681 / 10335874 | 00630414526744 | On the market | |
| CHOL CH3810 | CH3810 / CH3810 | 05055273201284 | On the market |
Similar devices
Other devices filed under FDA product code CHH (Enzymatic Esterase--Oxidase, Cholesterol).
- Lipids by Truvian Health
- HI CHEM KINETIC CHOLESTEROL REAGENT #88218 by Hichem Diagnostics
- ASTRA SYSTEMS CHOLESTEROL REAGENT by Beckman Instruments, Inc.
- ACCESSORY HDL CHOLESTEROL REAGENT SET by The Dow Chemical Co.
- MTM BIOSCANNER C TEST STRIPS by Polymer Technology Systems, Inc.
- CHOL by Abbott Laboratories
- MULTICHEM ENZYMATIC CHOLESTEROL SYS by SIMMLER INC
- SOLID PHASE DETER SERUM CHOLESTEROL FR WHOLE BLOOD by Chem-Elec, Inc.
- CHOLESTEROL REAGENT by Smithkline Diagnostics, Inc.
- ACE CHOLESTEROL REAGENT, ACE HDL-C REAGENT, ACE LDL-C REAGENT, ACE TRIGLYCERIDES REAGENT by Alfa Wassermann Diagnostic Technologies, Inc.